Literature DB >> 33580614

Prognostic values and immune suppression of the S100A family in pancreatic cancer.

Hongkai Zhuang1,2, Xinming Chen3, Fengying Dong4, Zedan Zhang1,2, Zixuan Zhou1, Zuyi Ma1,2, Shanzhou Huang1, Bo Chen5, Chuanzhao Zhang1, Baohua Hou1.   

Abstract

S100 calcium-binding protein A (S100A) family members regulate multiple biological functions related to pancreatic cancer (PC) progression and metastasis. However, the prognostic and oncologic values of S100A family have not been systematically investigated in PC. In the present study, the mRNA expression and potential functions of S100A family were investigated by bioinformatic analysis. Our results demonstrated that overexpression of S100A2, S100A6, S100A10, S100A11, S100A14 and S100A16 was significantly associated with higher T stage, advanced histologic grade and worse prognosis in PC. Besides, one CpG of S100A2, three CpG of S100A6, four CpG of S100A10, four CpG of S100A11, two CpG of S100A14 and five CpG of S100A16 were negatively associated with corresponding S100A family members expression and positively associated with overall survival (OS). The signature based on four CpGs showed good prediction ability of OS. Besides, S100A2 overexpression took part in the regulation of mitotic cell cycle, ECM-receptor interaction and HIF-1α transcription factor network. Overexpression of S100A6, S100A10, S100A11, S100A14 and S100A16 may impair the infiltration and cytolytic activity of CD8+ T cells through focal adhesion-Ras-stimulating signalling pathway in PC. Overall, this study explores the multiple prognostic values and oncologic functions of the S100A family in PC.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  CD8+ T cells; Ras-stimulating signalling pathway; S100A family; focal adhesion; pancreatic cancer

Year:  2021        PMID: 33580614      PMCID: PMC7957204          DOI: 10.1111/jcmm.16343

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  39 in total

1.  [Expression of S100A2 in secondarily radioresistant pancreatic cancer cells and significance thereof].

Authors:  Quan Wen; Yu-pei Zhao; Ge Chen; Fu-quan Zhang; Tai-ping Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2006-10-31

2.  Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.

Authors:  Yuanyuan Jiang; Hanxiang Zhan
Journal:  Cancer Lett       Date:  2019-10-09       Impact factor: 8.679

3.  S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.

Authors:  Patrick C Mahon; Patrick Baril; Vipul Bhakta; Claude Chelala; Krishna Caulee; Tomohiko Harada; Nicholas R Lemoine
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

Review 4.  Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.

Authors:  Vinod P Balachandran; Gregory L Beatty; Stephanie K Dougan
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

Review 5.  Pancreatic cancer.

Authors:  Terumi Kamisawa; Laura D Wood; Takao Itoi; Kyoichi Takaori
Journal:  Lancet       Date:  2016-01-30       Impact factor: 79.321

6.  Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.

Authors:  Hirozumi Sawai; Yuji Okada; Hitoshi Funahashi; Yoichi Matsuo; Hiroki Takahashi; Hiromitsu Takeyama; Tadao Manabe
Journal:  Mol Cancer       Date:  2005-10-06       Impact factor: 27.401

7.  Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation.

Authors:  Ching-Yi Liu; Hsi-Hui Lin; Ming-Jer Tang; Yang-Kao Wang
Journal:  Oncotarget       Date:  2015-06-30

8.  New landscapes and horizons in hepatocellular carcinoma therapy.

Authors:  Melchiorre Cervello; Maria R Emma; Giuseppa Augello; Antonella Cusimano; Lydia Giannitrapani; Maurizio Soresi; Shaw M Akula; Stephen L Abrams; Linda S Steelman; Alessandro Gulino; Beatrice Belmonte; Giuseppe Montalto; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

9.  Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

Authors:  Maartje G Schouwenburg; Karijn P M Suijkerbuijk; Rutger H T Koornstra; Anouk Jochems; Michiel C T van Zeijl; Alfons J M van den Eertwegh; John B A G Haanen; Maureen Jb Aarts; Alexander C J van Akkooi; Franchette W P J van den Berkmortel; Jan Willem B de Groot; Geke A P Hospers; Ellen Kapiteijn; Wim H Kruit; Djura Piersma; Rozemarijn S van Rijn; Albert J Ten Tije; Gerard Vreugdenhil; Jacobus J M van der Hoeven; Michel W J M Wouters
Journal:  Cancers (Basel)       Date:  2019-12-04       Impact factor: 6.639

10.  GSVA: gene set variation analysis for microarray and RNA-seq data.

Authors:  Sonja Hänzelmann; Robert Castelo; Justin Guinney
Journal:  BMC Bioinformatics       Date:  2013-01-16       Impact factor: 3.169

View more
  8 in total

1.  Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma.

Authors:  Ge Gao; Liqiang Wang; Changfeng Li
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 2.  Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling.

Authors:  Jian Gao; Xiaodong Zhang; Lei Jiang; Yan Li; Qianqian Zheng
Journal:  Cell Commun Signal       Date:  2022-06-25       Impact factor: 7.525

3.  Prognostic values and immune suppression of the S100A family in pancreatic cancer.

Authors:  Hongkai Zhuang; Xinming Chen; Fengying Dong; Zedan Zhang; Zixuan Zhou; Zuyi Ma; Shanzhou Huang; Bo Chen; Chuanzhao Zhang; Baohua Hou
Journal:  J Cell Mol Med       Date:  2021-02-12       Impact factor: 5.310

4.  Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.

Authors:  Xiaomin Li; Ning Qiu; Qijuan Li
Journal:  Front Genet       Date:  2021-11-03       Impact factor: 4.599

Review 5.  The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.

Authors:  Ashna A Kumar; Benjamin J Buckley; Marie Ranson
Journal:  Biomolecules       Date:  2022-01-18

6.  A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients.

Authors:  Yue Wang; Jian Feng; Yang Liu; Tingyue Han
Journal:  Comput Math Methods Med       Date:  2022-09-28       Impact factor: 2.809

Review 7.  The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.

Authors:  Alamelu G Bharadwaj; Emma Kempster; David M Waisman
Journal:  Biomolecules       Date:  2021-11-26

8.  Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma.

Authors:  Dongjie Chen; Hui Huang; Longjun Zang; Wenzhe Gao; Hongwei Zhu; Xiao Yu
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.